All the Active Ingredient Drugs
Anticholinergic agent. Glycopyrronium Bromide 0.2 mg/ml. Bottle.Oral sol. 150 ml X 0.2 mg/ml
Recommended for short-term intermittent use.
Dosage must be meas. and admin. with the grad. syringe incl. in the pack.
Dosing sched. is based on the BW with the initial dosing of 0.02 mg/kg to be given three times dly and titrate in increm. of 0.02 mg/kg every 5-7 days based on therap. resp. and adverse reactions. The max. recomm. dosage is 0.1 mg/kg three times dly. not to exceed 1.5-3 mg per dose based upon weight.
See prescribing information for full details
Symptom. tmt. of sev. sialorrhoea (chron. pathol. drooling) in child and adolesc. aged 3 years and older with chron. neurolog. dis.
C/I: Hypersens. / Angle-closure glaucoma/
Myasthenia gravis (large doses of quatern. ammonium compounds have been shown to antagonise end plate nicotinic receptors)/
Pyloric stenosis/Paralytic ileus/
Prostatic enlargement/ Urin. retent./
Sev. renal impairm. (eGFR <30 ml/min/1.73m2, incl. those req. dialysis/
Intestinal obstruct./ Pregnancy and breast-feeding.
Potassium chloride solid oral dose prod./Anticholinergic medic.
Adrenergics in combination with anticholinergics. Beclometasone Dipropionate 100 mcg, Formoterol fumarate dihydrate 6 mcg, Glycopyrronium Bromide 12.5 mcg. INHALER 1X 120 actuat. Pressurised sol. for inhal.
Recomm. and max. dose is two inhal. twice dly.
Pts. should be advised to take this drug every day even when asympt. Not for under 18 years old.
If sympt. arise between doses, inhaled, short-act. beta2-agon. should be used for immed. relief.
Maint. tmt. in adlt. pts. with mod. to sev. chron. obstr. pulm. dis. (COPD) who are not adeq. treat. by a combin. of inhal. corticost. and long-act. beta2-agon. or a combin. of a long-act. beta2-agon. and a long-act. muscar. antagonist.
Maint. tmt. of asthma, in adlts. not adeq. controll. with a maint. combin. of a long-act. beta2-agon. and medium dose of inhal. corticost., and who exper. one or more asthma exacerb. in the prev. year.
C/I: Hypersens.
Long-Acting Muscarinic Antagonist, Selective β2 Agonist. Glycopyrronium Bromide 50 mcg, Indacaterol Maleate 110 mcg. INH. PWDR. (hard caps.): 6, 12, 30 hard
caps., w/inhaler. 1 cap. once dly. Admin.
same time each day. Not for under 18
yrs.
Maint. bronchodil. tmt. to relieve sympt.
in adult pts. with COPD.
C/I: Hypersens.
